I’ve received my Software (TAN) Code via email but my Username and Password has not arrived by post. How long does this normally take?

Your Username and Password should arrive within five days of the email, addressed to the End User Location Contact at the End User Location provided during registration.

If your Username and Password has not arrived within 10 days of the email, please contact the SecurMed Service Desk.

Back Back

Related articles

Will Community/Hospital Pharmacies be able to return stock to their Wholesaler or a DTP manufacturer’s distributor?

This depends upon the terms and conditions of both the Wholesaler and the manufacturer. However, in general, we expect the current returns process will remain valid as long as the stock has not been decommissioned and the anti-tamper device is still intact.

First Login to UK MVS - Quick Start Guide - Step 1

Ready to log in to the UK MVS? Please follow the links to instructions below.

Does Article 37(d) require that a National Medicine Verification Organisation (NMVO) directly alerts the relevant national competent authorities, the EMA and the Commission about a falsification? Is there is a time limit for such alerting?

The use of the term “provide for” in Article 37(d) of Commission Delegated Regulation (EU) 2016/161 means that an NMVO has to ensure that the National Competent Authorities (NCA), the EMA and the Commission are informed.

Is Gibraltar in scope of the FMD implementation and what about British Crown Dependencies and British Overseas Territories?

MHRA have confirmed with the UK Foreign Office that the Crown Dependencies of Jersey and Guernsey (including the other Channel Islands) and the Isle of Man are included within the FMD implementation. Gibraltar and all other British Overseas Territories e. g.

Where can I find a copy of the Delegated Regulation?

You can find the Delegated Regulation here.

Which medicines are in scope of FMD?

For details of the scope of the regulation please check: FMD Delegated Regulation 2016_161

Where stakeholders are unclear on the legislation, for example whether types of medicine are in/out of scope, please contact DHSC/MHRA at fmd. safetyfeatures@mhra. gov. uk.

This website uses cookies

We use cookies to give you a better experience. By continuing to use our site, you are agreeing to the use of cookies as set in our Cookie Policy.

Accept all cookies Manage cookie settings